ティッシュエンジニアリング (組織工学) 市場 - 分析、規模、シェア、動向、予測：2020年～2026年
Tissue Engineering Market, By Types, By Application, By End Users, and By Geography - Analysis, Size, Share, Trends, & Forecast from 2020-2026
|ティッシュエンジニアリング (組織工学) 市場 - 分析、規模、シェア、動向、予測：2020年～2026年|
発行: AnalystView Market Insights
ページ情報: 英文 248 Pages
ティッシュエンジニアリング (組織工学) 市場は、2018年に97億5000万米ドルに達し、2020年～2026年の予測期間中のCAGRで、16.8％の成長が予測されています。
当レポートでは、世界のティッシュエンジニアリング (組織工学) 市場について調査分析し、市場概要、市場力学、セグメント別の市場分析、競合情勢などについて、体系的な情報を提供しています。
Tissue engineering market was valued at USD 9.75 billion by 2018, growing with 16.8% CAGR during the forecast period, 2020-2026.
Tissue engineering can be defined as a practice that involves improvement or replacement of biological tissue by application of physiochemical & biochemical factors, cells & engineering, and material methods. The primary intention of this approach is the structural or functional restoration of human cells through the delivery of living elements which becomes integrated in patients. This method is widely used for cosmetic surgeries, treatment of accident wounds, wound care, traumas, orthopedics, correction of birth defects, and others. In tissue engineering, engineering materials are used as living cells to solve problems. In addition, this interdisciplinary field also helps with the shortage of life-saving organs that are available through donation for transplantation.
The increased adoption of tissue engineering in the field of regenerative medicine and its potential to treat irreversible damage of tissues are major factors boosting the growth of the global tissue engineering market. In addition, a rise in healthcare expenditure, a surge in funding for research & development from private companies and governments, and the rise in the number of accidents and traumas all over the world are other factors impelling the overall market growth.
Moreover, technological advancements in the 3D engineering field and FDA approvals for tissue-engineered products are likely to create lucrative growth opportunities in the worldwide market during the forecast period. For instance, in September 2019, Zimmer Biomet got 510(k) clearance from the FDA for its JuggerStitch meniscal repair device, which is the next generation of innovative meniscus repair technology. Conversely, product failures & recalls and high treatment costs associated with tissue engineering are predicted to impede the market growth in the coming future. However, it is noted that this technology offers profound benefits and an enormous potential which provides future promise in the treatment of genetic disorders as well as organ failure.
By types, the worldwide tissue engineering market is categorized into synthetic and biologically derived material. Of these, the biologically derived material accounted for the majority of market share in 2019 and is anticipated to witness noteworthy growth during the forecast period. This is mainly due to rising incidences of tissue injury, malfunctioning, tissue injury and growing occurrences of road accidents all across the globe.
On the other hand, the synthetic material segment is estimated to expand at the highest growth rate by the end of 2026 owing to increasing demand from the biomedical field because of their properties such as mechanical characteristics, porosity, and degradation time.
Based on application, the overall market is bifurcated into dental, skin & integumentary, urology, orthopedics, musculoskeletal, & spine, neurology, cord blood & cell banking, cancer, gynecology, and cardiology & vascular. Among these, the orthopedics, musculoskeletal, & spine segment played a leading role in the market in 2019 and is projected to continue its dominance throughout the forecast. This dominance is attributed to a surge in the prevalence of musculoskeletal disorders all across the globe. According to the statistics provided by the World Health Organization (WHO), there are nearly 70 million physician office visits in the U.S. every year. In addition, the existence of pipeline products by major market players is anticipated to make a considerable contribution to the segmental growth in the coming years.
On the other hand, the cardiology & vascular segment is estimated to witness the highest growth during the period of forecast owing to a hasty increase in the occurrence of cardiovascular disorders all over the world. Besides, the prominent players of the industry are focused on the continuous development of stem cell therapies in order to repair, reinstate, and re-vascularize the heart tissues that are damaged. Moreover, technological advancements in tissue engineering will propel the segmental market growth by 2026.
End User Takeaway
By end-users, the global market is categorized into hospitals & clinics and ambulatory facilities. The hospitals and clinics accounted for the largest market share in 2019 and are anticipated to grow exponentially during the forecast period. This growth is primarily owing to the increased number of visits to hospitals & clinics due to a rise in the number of road accidents, trauma injuries, orthopedics, musculoskeletal, and spine injuries. In addition, hospitals are mostly preferred by patients for surgeries because of its well-established infrastructure. This is expected to drive the growth of hospitals & clinics segment in the coming future.
Regionally, the overall market is divided into North America, Middle East & Africa, Asia Pacific, Latin America, and Europe. The North America market for tissue engineering registered for the majority of share in 2019 owing to the rising geriatric population and growing awareness for stem cell therapy. In addition, technological advancements for diagnosis & treatment of chronic disorders, rising healthcare expenditure, and availability of government & private funding are fuelling the regional market growth.
On the other hand, the Asia Pacific is anticipated to be the fastest-growing region throughout the forecast owing to the growing prevalence of clinical disorders such as cancer and technological advancements in the field of tissue engineering. In addition, rising medical tourism and the evolution of 3D bioprinting are also contributing to the regional market growth.
The tissue engineering market is adversely affected due to the sudden outbreak of COVID-19 all over the globe. Traditionally, tissue engineering has focused on the biological systems, application of engineering principles, rapid translation of technologies, and collaboration across disciplines. Given these strengths, the tissue engineers are on the whole well-suited to apply their skillset to the overcome current COVID-19 crisis in general. Thus, highlighting important developments in the tissue engineering field, which are relevant to the current pandemic will help the global market to sustain in the near future.
Key Vendor Takeaway
The leading players of the global tissue engineering market include Medtronic, Zimmer, Acelity, CryoLife, Sanofi, BioMimetic Therapeutics, StemCells Inc., LifeCell Kinetic Concepts, ACell, Inc., Athersys, Inc., Organogensis, Inc., Stryker Corporation, Tissue Regenix Group plc, RTI Surgical, Inc., ReproCell, Inc., Integra LifeSciences, Advanced Cell Technology, Cook Biotech, and Arteriocyte.
In February 2018, Integra LifeSciences acquired Derma Sciences and its line of regenerative allograft products, which are derived from human placental tissue. This acquisition helped the company to obtain a strong position in the global industry.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2015 to 2018
Base Year - 2019
Estimated Year - 2020
Projected Year - 2026
Traders, Distributors, and Suppliers
Government and Regional Agencies
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
TISSUE ENGINEERING MARKET KEY PLAYERS
Tissue Regenix Group plc.
LifeCell Kinetic Concepts
Advanced Cell Technology
RTI Surgical, Inc.
TISSUE ENGINEERING MARKET, BY TYPES
TISSUE ENGINEERING MARKET, BY MATERIAL TYPE
TISSUE ENGINEERING MARKET, BY APPLICATION
Skin & Integumentary
Musculoskeletal and Spine
Cord Blood & Cell Banking
Obstetrics / Gynecology
Cardiology & Vascular
TISSUE ENGINEERING MARKET, BY END USERS
Hospitals & Clinics
TISSUE ENGINEERING MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
Middle East and Africa
United Arab Emirates
Rest of MEA